Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017

[1]  Z. Bhutta,et al.  Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015–2016 , 2017, The Pediatric infectious disease journal.

[2]  W. Weldon,et al.  Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria , 2016, Vaccine.

[3]  Steven G F Wassilak,et al.  Progress Toward Polio Eradication - Worldwide, 2015-2016. , 2016 .

[4]  Z. Iliyasu,et al.  Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011–2014 , 2016, The Journal of infectious diseases.

[5]  Polio vaccines: WHO position paper – March, 2016. , 2016, Releve epidemiologique hebdomadaire.

[6]  M. Pallansch,et al.  Standardized Methods for Detection of Poliovirus Antibodies. , 2016, Methods in molecular biology.

[7]  W. Weldon,et al.  Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014 , 2015, Journal of epidemiology and global health.

[8]  G. Armstrong,et al.  Possible Eradication of Wild Poliovirus Type 3 — Worldwide, 2012 , 2014, MMWR. Morbidity and mortality weekly report.

[9]  Roland W Sutter,et al.  The new polio eradication end game: rationale and supporting evidence. , 2014, The Journal of infectious diseases.

[10]  K. Wannemuehler,et al.  Combined Use of Inactivated and Oral Poliovirus Vaccines in Refugee Camps and Surrounding Communities — Kenya, December 2013 , 2014, MMWR. Morbidity and mortality weekly report.

[11]  M. Pate,et al.  Survey of poliovirus antibodies in Kano, Northern Nigeria. , 2014, Vaccine.

[12]  R. Sutter,et al.  Priming after a fractional dose of inactivated poliovirus vaccine. , 2013, The New England journal of medicine.

[13]  Apparent global interruption of wild poliovirus type 2 transmission. , 2001, MMWR. Morbidity and mortality weekly report.